Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in ADAPTIVE BIOTECHNOLOGIES COR
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 222,524 shares of ADPT (ADAPTIVE BIOTECHNOLOGIES COR), worth $3.1M as of 2026-Q1. The position was increased (+9.8% shares). ADPT represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$3.1M
Current Shares
222,524
Total Value Change
+$3.1M
Total Shares Change
+222,524
Other major holders of ADPT: VIKING GLOBAL INVESTORS LP
Increased |
| 222,524 |
+9.8% |
| $3.1M |
| 0.0% |
| $16.08 |
29 |
| 2025-Q4 | Increased | 202,725 | +40.2% | $3.3M | 0.0% | $16.42 | 35 |
| 2025-Q3 | Decreased | 144,635 | -45.8% | $2.2M | 0.0% | $13.46 | 0 |
| 2025-Q2 | Increased | 266,893 | +44.1% | $3.1M | 0.0% | $11.79 | 36 |
| 2025-Q1 | Increased | 185,236 | +56.2% | $1.4M | 0.0% | $7.67 | 36 |
| 2024-Q4 | New | 118,593 | - | $710,965 | 0.0% | $6.11 | 34 |
| 2024-Q2 | Exited | 0 | -100.0% | $0 | 0.0% | $3.62 | 0 |